Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence JA Belk, W Yao, N Ly, KA Freitas, YT Chen, Q Shi, AM Valencia, E Shifrut, ... Cancer cell 40 (7), 768-786. e7, 2022 | 154 | 2022 |
RASA2 ablation in T cells boosts antigen sensitivity and long-term function J Carnevale, E Shifrut, N Kale, WA Nyberg, F Blaeschke, YY Chen, Z Li, ... Nature 609 (7925), 174-182, 2022 | 89 | 2022 |
An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy BD Khalil, R Sanchez, T Rahman, C Rodriguez-Tirado, S Moritsch, ... The Journal of Experimental Medicine 219 (1), 2022 | 55 | 2022 |
NR2F1 is a barrier to dissemination of early-stage breast cancer cells C Rodriguez-Tirado, N Kale, MJ Carlini, N Shrivastava, AA Rodrigues, ... Cancer research 82 (12), 2313-2326, 2022 | 16 | 2022 |
Resistance to ATR inhibitors is mediated by loss of the nonsense-mediated decay factor UPF2 PC O'Leary, H Chen, YU Doruk, T Williamson, B Polacco, AS McNeal, ... Cancer research 82 (21), 3950-3961, 2022 | 11 | 2022 |
5-Azacytidine-and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling DK Singh, S Carcamo, EF Farias, D Hasson, W Zheng, D Sun, X Huang, ... Cell reports 42 (6), 2023 | 7 | 2023 |
A specific agonist of the orphan nuclear receptor NR2F1 suppresses metastasis through the induction of cancer cell dormancy BD Khalil, R Sanchez, T Rahman, C Rodriguez-Tirado, S Moritsch, ... bioRxiv, 2021.01. 30.428967, 2021 | 5 | 2021 |
Epigenetic reprogramming of DCCs into dormancy suppresses metastasis via restored TGFβ–SMAD4 signaling DK Singh, E Farias, S Carcamo, D Hasson, D Sun, J Cheung, AR Nobre, ... bioRxiv, 2021.08. 01.454684, 2021 | 3 | 2021 |
Ablation of cullin-5 in primary human T cells improves tumor killing and persistence in BCMA-targeting CAR-T cells in a multiple myeloma model S Bachl, A Talbot, C Ching, N Kale, Z Li, M Diolaiti, AP Chen, J Muldoon, ... Blood 142, 99, 2023 | 1 | 2023 |
5-Azacytidine-and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-b-SMAD4 signaling J Cheung, AR Nobre, N Kale, MS Sosa, E Bernstein Cell Reports 42, 112560, 2023 | | 2023 |
NR2F1 is a barrier to early dissemination of pre-malignant mammary cells MS Sosa, C Rodriguez-Tirado, N Kale, M Carlini, N Shrivastava, B Khalil, ... Cancer Research 81 (13_Supplement), 2837-2837, 2021 | | 2021 |
NR2F1 is a barrier to dissemination of early-evolved mammary cancer cells C Rodriguez-Tirado, N Kale, MJ Carlini, N Shrivastava, B Khalil, ... bioRxiv, 2021.01. 29.428822, 2021 | | 2021 |
NR2F1 limits dissemination of early cancer mammary epithelial cells MS Sosa, N Kale, N Shrivastava, C Rodriguez-Tirado, M Carlini, J Ji, ... Cancer Research 80 (16_Supplement), 6061-6061, 2020 | | 2020 |